Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

Example Group: InterventionDefinition: Sodium-Glucose Transport Protein 2 (SGLT2) inhibitors

Generated Narrative: Group 236769

version: 63; Last updated: 2024-12-14 08:46:28+0000

Profile: ExposureDefinition

Artifact Author: Computable Publishing®: MAGIC-to-FEvIR Converter:

Artifact related artifact: No display for RelatedArtifact (type: part-of; resourceReference: ->display: string (PrimitiveType/Group.extension[1].value[x].resourceReference.display): element = string -> display=string[MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes])

url: https://fevir.net/resources/Group/236769

identifier: FEvIR Object Identifier/https://fevir.net/FOI/236769, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-intervention-85394-I-85798

name: Sodium_Glucose_Transport_Protein_2_SGLT2_inhibitors85394_I_85798

title: InterventionDefinition: Sodium-Glucose Transport Protein 2 (SGLT2) inhibitors

status: Active

publisher: Computable Publishing LLC

contact: support@computablepublishing.com

description:

This Group Resource is referenced in an example for the EBMonFHIR Implementation Guide.

UseContexts

-CodeValue[x]
*Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence CommunicationExposureDefinition

copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

membership: Conceptual